Matthew Reynolds, MD, MSc

Dr. Reynolds’ studies the impact of new cardiovascular technologies on health care costs and quality of life at Baim where he leads the group executing this research and the analyses. With clinical interests in atrial fibrillation, catheter ablation, implantable defibrillators, and pacemakers, he has an active clinical electrophysiology practice at Lahey Hospital & Medical Center.

Board-certified in Cardiovascular Medicine and Electrophysiology, he received his medical degree from the University of Pennsylvania, a Master’s in Health Policy & Administration from the Harvard School of Public Health, and  he completed his training in Internal Medicine, Cardiology, and Cardiac Electrophysiology at Beth Israel Deaconess Medical Center in Boston. He is an Associate Professor of Medicine at Tufts University School of Medicine and a co-author of the 2017 consensus statement on catheter and surgical ablation of atrial fibrillation. He has contributed to or authored publications on anticoagulation, stents, peripheral artery disease, AV malformations and numerous manuscripts covering a range of topics in atrial fibrillation.